These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7578875)

  • 1. Glycolipids as the major autoantigens of cytoplasmatic islet cell antibodies.
    Cabrera-Rode E; Diaz-Horta O; Fernandez LE; Carr A; Marquina G; Valiente O; Gonzalez-Suarez RM; Uriarte A
    Autoimmunity; 1995; 20(3):145-51. PubMed ID: 7578875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytoplasmic islet cell antigens by rat pancreas.
    Dib SA; Colman PG; Dotta F; Tautkus M; Rabizadeh A; Eisenbarth GS
    Diabetes; 1987 Aug; 36(8):982-5. PubMed ID: 3109988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
    Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
    Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
    Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
    J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
    Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
    Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.
    Baekkeskov S; Landin M; Kristensen JK; Srikanta S; Bruining GJ; Mandrup-Poulsen T; de Beaufort C; Soeldner JS; Eisenbarth G; Lindgren F
    J Clin Invest; 1987 Mar; 79(3):926-34. PubMed ID: 3546382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
    Lan MS; Wasserfall C; Maclaren NK; Notkins AL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
    Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
    J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T; Hirata Y; Maruyama H; Ishiba S; Matuura N; Fukushima N; Wakisaka A
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():265-9. PubMed ID: 6393434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
    Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.